Yes, Soma is a muscle relaxer. Its generic name is carisoprodol, and it’s FDA-approved for short-term relief of discomfort from acute, painful musculoskeletal conditions in adults. It’s classified as a Schedule IV controlled substance due to its potential for dependence, which places it in a more restricted category than many other muscle relaxants.
How Soma Works
Soma is a centrally acting muscle relaxant, meaning it works in the brain and spinal cord rather than directly on your muscles. The exact mechanism isn’t fully understood, but animal studies suggest it alters nerve signaling in the spinal cord and a part of the brainstem involved in muscle tone. The result is reduced muscle tension and pain relief, but the drug isn’t doing anything to the muscle tissue itself.
Part of what makes Soma distinctive is what your body turns it into. As your liver processes carisoprodol, one of the byproducts is meprobamate, a compound with sedative and anti-anxiety effects similar to older barbiturate-type drugs. This metabolite is a key reason Soma carries a controlled substance classification and a risk of habit formation that other muscle relaxants don’t share to the same degree.
What Soma Is Prescribed For
Soma is intended for acute musculoskeletal pain, the kind that comes from a back sprain, muscle strain, or similar injury. It’s meant to be used alongside rest and physical therapy, not as a standalone long-term treatment. Prescriptions are typically limited to two or three weeks because there’s no evidence supporting longer use, and the risk of dependence increases with time.
In clinical trials involving over 1,300 patients with acute lower back spasms, both the 250 mg and 350 mg doses significantly outperformed placebo for pain relief and overall improvement. Patients reported meaningful differences as early as day two of treatment, and the benefits held through day seven. Notably, the lower 250 mg dose performed just as well as the 350 mg dose, which matters because the higher dose caused more side effects.
Dosage and How It’s Taken
Soma comes in 250 mg and 350 mg tablets. The standard recommendation is one tablet three times a day and once at bedtime. Since the two doses showed equal effectiveness in trials, many prescribers opt for the 250 mg version to minimize sedation.
Common Side Effects
The most frequently reported side effects are drowsiness, dizziness, and headache. In controlled studies, drowsiness affected 13% of patients on the 250 mg dose and 17% on the 350 mg dose, compared to 6% on placebo. Dizziness showed a similar pattern: 8% at 250 mg and 7% at 350 mg versus 2% on placebo. Headache occurred in about 3% to 5% of patients taking Soma.
One important finding from those trials: the pain relief Soma provides isn’t simply a byproduct of making you drowsy. Researchers confirmed that its effectiveness didn’t depend on sedation, meaning the drug has a genuine muscle-relaxant effect beyond just making people sleepy. Still, the sedation is real enough that driving or operating machinery can be risky while taking it.
Why Soma Is a Controlled Substance
Carisoprodol became a Schedule IV controlled substance under federal law because of its abuse and dependence potential. The meprobamate it produces in your body has well-documented barbiturate-like properties, which can create feelings of relaxation or euphoria that some people find habit-forming. This is the same reason Soma is sometimes misused recreationally, particularly in combination with other sedating drugs.
Both tolerance (needing more to get the same effect) and physical dependence have been reported with prolonged use. If someone stops Soma abruptly after taking it for an extended period, withdrawal symptoms can include insomnia, vomiting, abdominal cramps, headache, tremors, muscle twitching, anxiety, and in severe cases, hallucinations or psychosis. Tapering off gradually under medical supervision avoids these problems.
How Soma Compares to Other Muscle Relaxants
Not all muscle relaxants carry a controlled substance designation. Cyclobenzaprine (Flexeril) and methocarbamol (Robaxin), for instance, are not scheduled drugs, which makes them a first choice for many prescribers treating the same types of acute musculoskeletal pain. Soma tends to be reserved for cases where other options haven’t worked, precisely because of its dependence risk and the meprobamate issue.
That said, some patients respond better to Soma than to alternatives, and its relatively fast onset of relief is one reason it remains in use. The key distinction is that Soma’s controlled status means prescriptions may be harder to get refilled, quantities may be limited, and your prescriber will likely keep the treatment course short.